2.
肺癌患者组和其它肺部疾病组间的血清差异性代谢物
Significantly changed metabolites in serum of lung cancer and other lung diseases
| Metabolites | P* | Tendency | Ratio (lung cancer/other lung diseases) |
| *Statistical P-value calculated using a two sample t-test (significance at P < 0.05); ↑: The level of the metabolites is higher in lung cancer than in other lung diseases; ↓: The level of the metabolites is lower in lung cancer than in other lung diseases. | |||
| Pyruvate | < 0.000, 001 | ↑ | 1.86 |
| Lactate | 0.000, 099 | ↑ | 1.54 |
| Alanine | 0.001, 044 | ↑ | 1.44 |
| 2-Hydroxy butanate | 0.000, 007 | ↑ | 2.38 |
| Ethanedioic acid | 0.000, 081 | ↑ | 1.85 |
| 3-Hydroxy butanate | 0.000, 007 | ↑ | 1.84 |
| Glyceral | 0.000, 302 | ↑ | 1.78 |
| Proline | 0.000, 189 | ↑ | 1.55 |
| Ribitol | 0.013, 100 | ↓ | 0.91 |
| Citrate | 0.000, 445 | ↑ | 2.00 |
| Lysine | 0.002, 043 | ↓ | 0.69 |
| Hexadecanoic acid | 0.030, 245 | ↑ | 1.39 |
| 9, 12-Octadecadienoic acid | 0.000, 008 | ↑ | 1.69 |